Currently, common clinical GLP-1RAs include exenatide and exenatide-LAR [34,35,36,37,38,39,40], lixisenatide [41,42,43,44], beinaglutide [45], liraglutide [46,47,48,49,50,51,52,53], semaglutide [54,55,56,57,58], albiglutide [59,60,61], dulaglutide [62,63,64], oral semaglutide [58, 65,66,67], PEG-loxenatide [68] and tirzepatide [68,69,70,71,72,73] (Table 1)
Protects endothelial cells and mitigates damage caused by toxins, stress, and inflammation
Provides antioxidant protection , reducing oxidative stress and promoting healthy aging
A related study revealed that the peripheral administration of D-glucose significantly enhances morphine-mediated antinociception, suggesting a synergistic interaction between the glucose and opioid pathways 48
To Note
Dihexa, research compound, third party tested, COA available, Disguised Alpha, Encapsulated Products Dihexa is commonly positioned around HGF/c-Met pathway research, neurotrophic signaling models, cognitive pathway studies